1999
DOI: 10.1046/j.1365-2133.1999.02922.x
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of the expression of known basement membrane components with the linear IgA disease antigens using the novel substrate cylindroma

Abstract: Linear IgA disease (LAD) is characterized by IgA basement membrane zone autoantibodies. Immunofluorescence, immunoblotting and immunoelectron microscopy studies have established the complexity and heterogeneity of the target antigens. We have studied the expression of the LAD antigens by cylindroma, a benign epithelial tumour that secretes abundant basement membrane, using 57 LAD sera categorized by indirect immunofluorescence on intact and salt-split skin. The expression of known components of hemidesmosomes,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

2000
2000
2021
2021

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 32 publications
(118 reference statements)
1
7
0
Order By: Relevance
“…A similar picture of heterogeneous target antigens has been found in idiopathic LAD; 28 investigators have identified BP180 29–31 and its extracellular domain (LAD1; 97 kDa/120 kDa), 26,30–33 BP230, 29–31,34 collagen VII, 30,31 , 35–37 antigens of molecular weight 285 kDa, 16,30 , 31 280 kDa 38 (possibly the same as the 285 kDa antigen), 200 kDa, 30,31 , 38 160/170 kDa, 140 kDa and other antigens of < 100 kDa, 30 as targets. Some patients with idiopathic LAD have multiple target antigens, but previously this has not been reported in drug‐induced LAD.…”
Section: Discussionsupporting
confidence: 66%
“…A similar picture of heterogeneous target antigens has been found in idiopathic LAD; 28 investigators have identified BP180 29–31 and its extracellular domain (LAD1; 97 kDa/120 kDa), 26,30–33 BP230, 29–31,34 collagen VII, 30,31 , 35–37 antigens of molecular weight 285 kDa, 16,30 , 31 280 kDa 38 (possibly the same as the 285 kDa antigen), 200 kDa, 30,31 , 38 160/170 kDa, 140 kDa and other antigens of < 100 kDa, 30 as targets. Some patients with idiopathic LAD have multiple target antigens, but previously this has not been reported in drug‐induced LAD.…”
Section: Discussionsupporting
confidence: 66%
“…Twenty‐six patients who satisfied the 1982 American Rheumatism Association criteria 4 for SLE were recruited from the Connective Tissue Diseases Clinic, John Radcliffe Hospital. After informed consent, nonlesional skin biopsies were taken from the medial aspect of the forearm for the lupus band test (LBT) using a standard direct immunofluorescence technique, 5 to study expression of the main components of the skin BMZ in nonlesional SLE skin by an indirect immunofluorescence microscopy method 6 before the colocalization study. The following well‐characterized monoclonal antibodies (Table 1) were used for immunolabelling of the different parts of the BMZ: LH7.2 directed against the NC1 domain of collagen type VII, anticollagen IV, GB3 to the γ‐chain of laminin‐5, G71 to β 4 ‐integrin, antifibronectin, antilaminin‐1, and 10E4 to heparan sulphate proteoglycans.…”
Section: Patients and Tissue Samplesmentioning
confidence: 99%
“…Our own studies using cylindroma tissue as a substrate have suggested that LAD autoantibodies may react with four major antigens, two epidermal and two dermal 31 . A preliminary IB study on 63 LAD sera showed that up to nine target antigens were recognized by IgA autoantibodies in epidermal and dermal tissue extracts, including BP230, BP180, collagen VII, the uncharacterized LAD285, and other less well recognized antigens 7 .…”
mentioning
confidence: 99%